Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children

Journal of Infectious Diseases

Volumn 182, Issue 6, 2000, Pages 1769-1773

  Zhu, Jianhui ^a   Quyyumi, Arshed A ^b   Norman, James E ^c   Costello, Rene ^b   Csako, Gyorgy ^b   Epstein, Stephen E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; NELFINAVIR; OXAZINES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; TIME FACTORS;

EID: 0033696630     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317621     Document Type: Article

References (15)

1. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team
2. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
3. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team; ACTG Virology Committee Resistance and HIV-1 RNA Working Groups
4. + lymphocyte count in HIV-infected infants and children
5. Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children
6. Public Health Service task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV I transmission in the United States
7. Report of the NIH Panel to Define Principles of Therapy of HIV Infection
8. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control
9. Combination therapy with efavirenz, nelfinavin and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team
10. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
11. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants
12. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
13. Viral dynamics in human immunodeficiency virus type 1 infection
14. Decay characteristics of HIV-1-infected compartments during combination therapy
15. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection